Skip to main content
TipRanks
Go Ultimate75% OFF

EZZ Life Science Holdings Ltd. (EZZ) Ratios

19 Followers

EZZ Life Science Holdings Ltd. Ratios

AU:EZZ's free cash flow for Q4 2026 was AU$-3.27M. For the 2026 fiscal year, AU:EZZ's free cash flow was decreased by AU$-5.80K and operating cash flow was AU$-3.27M. See a summary of the company’s cash flow.

Financial ratios
RatiosJun 26Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio8.705.775.965.794.96
Quick Ratio7.355.355.635.514.85
Cash Ratio3.263.644.554.713.72
Solvency Ratio-1.541.231.741.250.50
Operating Cash Flow Ratio-2.940.761.471.370.68
Short-Term Operating Cash Flow Coverage-24.710.0049.6011.3218.19
Net Current Asset ValueAU$ 22.80MAU$ 27.17MAU$ 20.68MAU$ 13.95MAU$ 11.09M
Leverage Ratios
Debt-to-Assets Ratio0.020.010.000.030.01
Debt-to-Equity Ratio0.020.010.010.030.01
Debt-to-Capital Ratio0.020.010.010.030.01
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.131.211.201.211.25
Debt Service Coverage Ratio-13.52260.3549.6710.4713.17
Interest Coverage Ratio-381.81356.76392.52443.44370.24
Debt to Market Cap0.020.000.000.020.01
Interest Debt Per Share0.010.010.000.010.00
Net Debt to EBITDA1.51-1.85-1.82-2.62-5.45
Profitability Margins
Gross Profit Margin55.68%74.35%76.67%73.24%49.98%
EBIT Margin-14.28%15.84%15.03%13.22%11.88%
EBITDA Margin-13.22%16.60%15.62%13.71%12.67%
Operating Profit Margin-14.28%14.85%14.62%12.43%10.93%
Pretax Profit Margin-13.86%15.83%14.99%13.19%11.85%
Net Profit Margin-11.50%10.06%10.48%9.77%8.74%
Continuous Operations Profit Margin-11.50%10.06%10.48%9.77%8.74%
Net Income Per EBT83.02%63.58%69.93%74.07%73.74%
EBT Per EBIT97.05%106.60%102.50%106.18%108.37%
Return on Assets (ROA)-19.26%19.82%27.26%20.58%9.20%
Return on Equity (ROE)-21.73%23.96%32.66%24.89%11.53%
Return on Capital Employed (ROCE)-26.80%35.18%45.46%31.38%14.35%
Return on Invested Capital (ROIC)-21.93%22.13%31.43%22.18%10.39%
Return on Tangible Assets-19.28%19.84%27.28%20.60%9.21%
Earnings Yield-31.01%6.23%8.79%17.00%9.96%
Efficiency Ratios
Receivables Turnover9.3414.6724.8526.776.55
Payables Turnover10.024.965.676.4510.32
Inventory Turnover5.107.0511.0611.7424.05
Fixed Asset Turnover48.0175.13106.9061.52101.03
Asset Turnover1.671.972.602.111.05
Working Capital Turnover Ratio1.842.783.822.941.43
Cash Conversion Cycle74.183.11-16.67-11.8635.53
Days of Sales Outstanding39.0924.8814.6913.6455.73
Days of Inventory Outstanding71.5351.7633.0031.1015.18
Days of Payables Outstanding36.4473.5464.3656.5935.38
Operating Cycle110.6276.6447.6944.7370.91
Cash Flow Ratios
Operating Cash Flow Per Share-0.190.090.140.090.04
Free Cash Flow Per Share-0.190.090.130.090.04
Dividend Paid and CapEx Coverage Ratio-9.402.104.125.7210.21
Capital Expenditure Coverage Ratio-295.0916.6915.0139.44144.33
Operating Cash Flow Coverage Ratio-18.3114.3049.608.3918.19
Operating Cash Flow to Sales Ratio-0.190.070.090.110.13
Free Cash Flow Yield-51.23%3.79%7.23%18.32%14.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-3.3215.6011.385.8810.04
Price-to-Sales (P/S) Ratio0.371.621.190.570.88
Price-to-Book (P/B) Ratio0.703.853.721.461.16
Price-to-Free Cash Flow (P/FCF) Ratio-1.9526.4013.825.466.98
Price-to-Operating Cash Flow Ratio-1.9624.8212.905.326.93
Price-to-Earnings Growth (PEG) Ratio0.02-2.500.130.03-0.28
Enterprise Value Multiple-1.297.885.821.571.48
Enterprise Value7.92M87.51M60.37M8.00M2.82M
EV to EBITDA-1.297.885.821.571.48
EV to Sales0.171.310.910.220.19
EV to Free Cash Flow-0.9021.3810.532.041.49
EV to Operating Cash Flow-0.9020.109.831.991.48
Tangible Book Value Per Share0.520.610.490.340.27
Shareholders’ Equity Per Share0.520.610.490.340.27
Tax and Other Ratios
Effective Tax Rate0.170.360.300.260.26
Revenue Per Share0.981.451.540.870.35
Net Income Per Share-0.110.150.160.080.03
Tax Burden0.830.640.700.740.74
Interest Burden0.971.001.001.001.00
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.050.540.020.030.06
Stock-Based Compensation to Revenue0.000.000.000.000.01
Income Quality1.650.650.881.111.45

Currency in AUD